Last updated: October 20, 2026
Our Mission
MetroMedX helps readers distinguish reliable medication information from ambiguous brand searches and commercial listings. A question about Flagyl tablets needs different product evidence from a question about vaginal metronidazole gel, a rosacea skin cream or a multi-ingredient H. pylori capsule. We organize articles by those distinct intents so a reader can identify the relevant licensed professional, product label and regulatory source.
Our editorial goal is practical clarity: explain what a named product contains, why its route or concentration matters, how to verify a prescription and what evidence does not establish. We do not encourage self-diagnosis, self-prescribing, purchasing medicines without appropriate authorization or using antibiotics for conditions they do not treat.
Products and Conditions Covered
The site covers oral metronidazole immediate-release tablets, 375 mg capsules, extended-release tablets and prescription liquid forms such as LIKMEZ. Vaginal products include standard 0.75% gels, Vandazole and Nuvessa 1.3%; dermatologic products include MetroGel, MetroCream, MetroLotion, Noritate and approved generics as applicable. The same active ingredient does not make these products interchangeable.
We also discuss diagnosis-specific metronidazole use, including bacterial vaginosis, trichomoniasis, selected anaerobic infections and H. pylori combination therapy. Comparisons address other medicines such as clindamycin, tinidazole, secnidazole, ivermectin and azelaic acid. A comparison explains distinct clinical roles, not permission to switch treatments.
What U.S. Sources Can Establish
FDA approval records and the FDA Orange Book help identify approved finished products and relevant therapeutic-equivalence information. DailyMed supplies structured product labels, but a label or National Drug Code by itself does not prove that a product is FDA-approved or available at a specific pharmacy. CDC guidance can address clinical treatment choices, whereas the prescribing information addresses the precise approved product and its warnings.
| Source | Useful evidence | Cannot establish alone |
|---|---|---|
| FDA approval / Orange Book | Approval and product-specific equivalence | Local inventory or personal suitability |
| DailyMed labeling | Ingredients, routes, warnings and packaged forms | Real-time stock or endorsement |
| CDC / specialty guideline | Condition-specific clinical recommendations | A personalized prescription |
| Randomized study | Outcomes for studied population and regimens | Guaranteed individual success |
| Pharmacy catalog | A seller’s listing or quoted terms | License, authenticity or current supply |
Why Route and Form Matter
Oral metronidazole, intravaginal BV products and external skin preparations should not be grouped into an undifferentiated antibiotic catalog. A 0.75% vaginal gel cannot be substituted with a 0.75% rosacea skin gel. Modified-release tablets, capsules and suspensions have different pharmaceutical properties and dispensing instructions.
The same caution applies to combination regimens. Pylera contains bismuth subcitrate potassium, metronidazole and tetracycline, and its labeled regimen also uses omeprazole. A listing for generic metronidazole tablets alone does not represent the complete H. pylori product.
How We Select Evidence
For regulatory status and formulation-specific warnings, we favor identifiable FDA approval records and current product labeling. For BV and sexually transmitted infections, we use CDC recommendations while distinguishing them from individual labels and from newer research or professional guidance. For H. pylori, we differentiate the approved Pylera package directions from guideline recommendations for separately selected optimized bismuth quadruple therapy.
When evidence changes, dates and study conditions matter. A direct comparison is not the same as drawing conclusions from unrelated trials. We also avoid treating a discontinued branded package as evidence that all generics have disappeared or an approved generic as proof of current retail availability.
Editorial Independence and Commercial Referrals
Some MetroMedX pages may contain sponsored or affiliate referrals to independent third-party businesses. Qualifying visits or purchases may result in compensation. Such relationships do not establish a pharmacy’s license, product authenticity, medical suitability or current stock. They must not determine medical conclusions, and commercial links should be labeled appropriately.
MetroMedX is not the pharmacist, prescriber, telehealth provider, manufacturer or insurer in an outside transaction. Readers should verify the provider’s identity, professional authorization, current terms and privacy notice before sharing personal or payment information.
Medical Oversight Without Invented Credentials
Editorial checking of FDA records, source citations, dates and links is different from review by a qualified clinician. Our Medical Review Process describes when professional scrutiny is particularly important, and Medical Reviewer Standards describe identity and documentation requirements. We do not invent a physician biography or imply that every article has been medically reviewed.
Corrections and Limitations
Please report verifiable errors, outdated product information or broken authoritative links using the website contact form. Our Editorial Policy explains how evidence, revisions and paid relationships should be handled. These pages are educational and cannot determine whether a medicine is suitable for a particular person.
For symptoms, adverse effects, drug interactions or dosing questions, contact an appropriate licensed clinician or pharmacist. Urgent health problems need prompt medical care; website messages are not monitored as an emergency service.